Mylan N.V. (NASDAQ:MYL) Ratings Summary on Apr 17, 2018

April 17, 2018 - By Elizabeth Jones

Mylan N.V. (NASDAQ:MYL) Corporate Logo
During 2017 Q4 the big money sentiment increased to 3. That’s change of 2.67, from 2017Q3’s 0.33. 0 investors sold all, 1 reduced holdings as Mylan N.V. ratio is positive. 0 grew stakes while 3 funds took stakes. Funds hold 292,846 shares thus 88.91% more from 2017Q3’s 155,019 shares.
Gulf International State Bank (Uk) Limited invested in 0.08% or 139,930 shs. Van Hulzen Asset Mgmt Limited Liability Corp accumulated 120,545 shs or 1.55% of the stock. 337 are owned by Vantage Ltd Liability Corporation. Mirae Asset Global Invests Communication Limited has invested 0.01% in Mylan N.V. (NASDAQ:MYL).

Mylan N.V. (NASDAQ:MYL) Ratings Coverage

In total 14 analysts cover Mylan Inc (NASDAQ:MYL). “Buy” rating has 11, “Sell” are 0, while 3 are “Hold”. 79% are bullish. With $59.0 highest and $32.0 lowest [Target] Mylan Inc has $50.36 average [Target] or 23.67% above the current ($40.72) price. 24 are the (NASDAQ:MYL)’s analyst reports since October 20, 2017 according to StockzIntelligence Inc. On Thursday, January 25 the rating was maintained by Susquehanna with “Buy”. On Thursday, March 1 the firm has “Buy” rating given by UBS. On Monday, October 23 Mizuho maintained the shares of MYL in report with “Buy” rating. On Thursday, January 11 the stock of Mylan N.V. (NASDAQ:MYL) earned “Buy” rating by Goldman Sachs. On Thursday, January 4 the firm has “Buy” rating given by Citigroup. The stock rating was maintained by Mizuho with “Buy” on Thursday, April 12. On Thursday, March 1 the stock of Mylan N.V. (NASDAQ:MYL) has “Hold” rating given by Cantor Fitzgerald. On Friday, October 20 RBC Capital Markets maintained the shares of MYL in report with “Hold” rating. The stock rating was initiated by Guggenheim with “Buy” on Tuesday, December 12. On Thursday, April 12 the rating was upgraded by Leerink Swann to “Outperform”. Listed here are Mylan N.V. (NASDAQ:MYL) PTs and latest ratings.

12/04/2018 Broker: Mizuho Rating: Buy New Target: $51.0000 Maintain
12/04/2018 Broker: Leerink Swann Old Rating: Market Perform New Rating: Outperform Old Target: $44 Upgrade
09/04/2018 Broker: Morgan Stanley Rating: Buy New Target: $50.0000 Maintain
03/04/2018 Broker: RBC Capital Markets Rating: Hold New Target: $45.0000 Maintain
15/03/2018 Broker: Mizuho Rating: Buy New Target: $51.0 Maintain
06/03/2018 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Overweight Old Target: $39 New Target: $50 Upgrade
01/03/2018 Broker: UBS Rating: Buy New Target: $54.0 Maintain
01/03/2018 Broker: Cantor Fitzgerald Rating: Hold New Target: $41.0 Maintain
16/02/2018 Broker: J.P. Morgan Rating: Buy New Target: $53.0
06/02/2018 Broker: BMO Capital Markets Rating: Buy New Target: $50.0 Maintain

MYL reached $40.72 on during the last trading session after $0.1 change.Mylan N.V. has volume of 1.78 million shares. Since April 17, 2017 MYL has declined 5.23% and is downtrending. The stock underperformed the S&P 500 by 16.78%.

Mylan N.V., together with its subsidiaries, develops, licenses, makes, markets, and distributes generic, brand name, and over-the-counter products worldwide.The company has $20.96 billion market cap. The firm operates through three divisions: North America, Europe, and Rest of World.The P/E ratio is 31.32. It offers pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized, and cream or ointment forms.

Mylan N.V. (NASDAQ:MYL) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: